Health Care: Drugs

Tekmira Pharmaceuticals Corp (TKMR: NASDAQ)

$10.83 0.58 | 5.66%
07/31/15 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 10.25
52 Week High 29.93
52 Week Low 10.02
Avg. Daily Vol. (Mil) 0.68
Beta (3 year) -1.12
Share Related Items
Mkt Cap (Mil) 555.80
Shares Out (Mil) 54.22
Float (Mil) 37.80
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 9.50
Current Ratio 9.60
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings n.a.
Price/Sales 36.55
Price/Book 0.94
Price/Cash Flow -17.20
Per Share Data
Earnings -1.33
Sales 0.28
Book Value 10.95
Cash Flow -0.60
Business Summary
Tekmira Pharmaceuticals Corp is abiopharmaceutical business engaged in advancing novel RNA interference therapeutics and discovering, developing and commercializing a cure for patients suffering from chronic hepatitis B infection.
General Information
100 - 8900 Glenlyon Parkway
Burnaby, BC V5J 5J8
www.tekmira.com
Industry : Drugs
Sector: Health Care
Employees: 103
CEO: Dr. Mark J. Murray,PhD
Short Interest
Current Month (Mil) 5.23
Previous Month (Mil) 5.05
Short Interest Ratio (Days) 8.20
Management Effectiveness
Return on Equity n.a.
Return on Assets -4.20
Return on Investments -5.50
Profitability
Gross Margin n.a.
EBIT Margin n.a.
Profit Margin 0.00
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter